2Hosomi N, Noma T, Ohyama H, et al. Vascular proliferation and transforming growth factor-beta expression in pre- and early stage of diabetes mellitus in Otsuka Long-Evans Tokushima fatty rats.Atherosclerosis,2002,162:69-76.
3Stefoni S, Cianciolo G, Donati G, et al.Low TGF-beta1 serum levels are a risk factor for atherosclerosis disease in ESRD patients. Kidney Inte,2002 ,61: 324-335.
4Glass C K, Witztum J L. Atherosclerosis. the road ahead. Cell, 2001,104: 503-516.
5Lutgens E, Gijbels M, Smook M, et al..Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression.Arteriosclerosis, Thromb Vasc Biol, 2002,22:975-982.
6Dong C, Zhu C, Wang T, et al. Upregulation of PAI-1 is mediated through TGF-beta/Smad pathway in transplant arteriopathy.J Heart Lung Transplant,2002,21:999-1008.
7Rifai N,Joubran R,Yu H, et al.Inflammatory warkers in men with angiograhically documented coronary heart disease. Clin Chem, 1999,45:1967-1973.
8Tsai My. Laboratory assessment of mild hyperhomocysteinemia as an indepent risk for occusive.Clin Chem,1996,42:492-493.
9Fu M L, Herlitz H, Wallukat G, et al. Non-desensi tized positive chronotropic effect of anti-angiotension Ⅱ receptor autoantibodies in patient with malignant hypertension. Circulation, 1996,94:4046(Abstr).
10Wallukat G, Homuth V, Fischer T,et al. Patients with preeclampsia develop agonistic antibodies against the angiotension AT1 receptor. J Clin Invest, 1999,1103: 945-952.
